The US is the biggest market for prescription drugs, accounting for roughly $600bn of annual sales out of a global $1tn or so ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Less than a month before Trump announced plans to cut drug prices, two politicians sold shares in AbbVie (NYSE: ABBV).

Pharmaceutical stocks often outperform during market downturns because they pay dividends and their products are mostly ...

Investors eyeing AbbVie have fresh options to chew on, thanks to new contracts expiring June 27. The $180 put option offers a ...

For the last few months, not a day has gone by where tariffs haven’t been on the tip of everyone’s tongue. The economic ...

AbbVie stands to benefit from a policy change eliminating the “pill penalty” in Medicare’s drug price negotiations, offering ...

Johnson & Johnson JNJ and AbbVie ABBV are two major U.S. pharmaceutical companies with robust pipelines and global operations ...

After a two-year surge of 53%, the stock market has been taken for a wild ride in 2025, driven by uncertainties surrounding ...

Investors often view Pharmaceutical stocks as safe havens during periods of market turbulence. Indeed, shares of the three ...

Ironwood Pharmaceuticals, Inc.’s IRWD share price has surged by 5.57%, which has investors questioning if this is right time ...